Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin A Walter

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2009
Noninvasive prediction of tumor responses to gemcitabine using positron emission tomographyRachel E Laing, Martin A Walter, Dean O Campbell, et al.
Journal of Translational Medicine|January 17, 2013
Somatostatin-based radiotherapy with [90Y-DOTA]-TOC in neuroendocrine tumors: long-term outcome of a phase I dose escalation studyNicolas Marincek, Ann-Catherine Jörg, Philippe Brunner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 23, 2018
MEK Inhibition Induces Therapeutic Iodine Uptake in a Murine Model of Anaplastic Thyroid CancerOussama ElMokh, Vincent Taelman, Piotr Radojewski, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 28, 2010
Small-animal PET/CT for monitoring the development and response to chemotherapy of thymic lymphoma in Trp53-/- miceMartin A Walter, Isabel J Hildebrandt, Katrin Hacke, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 15, 2011
Metabolic imaging allows early prediction of response to vandetanibMartin A Walter, Matthias R Benz, Isabel J Hildebrandt, et al.
Cancer|November 6, 2009
Procalcitonin levels predict clinical course and progression-free survival in patients with medullary thyroid cancerMartin A Walter, Christian Meier, Tanja Radimerski, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 18, 2010
Correlation of 6-18F-fluoro-L-dopa PET uptake with proliferation and tumor grade in newly diagnosed and recurrent gliomasBarbara J Fueger, Johannes Czernin, Timothy Cloughesy, et al.
JAMA Oncology|February 15, 2019
Therapeutic Options for Neuroendocrine Tumors: A Systematic Review and Network Meta-analysisReto M Kaderli, Marko Spanjol, Attila Kollár, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 18, 2009
18F-FDOPA PET and PET/CT accurately localize pheochromocytomasFarzin Imani, Vatche G Agopian, Martin S Auerbach, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 11, 2017
Reply: Diabetes Mellitus and Its Effects on All-Cause Mortality After Radiopeptide Therapy for Neuroendocrine Tumors: Methodologic IssuesMaria Umlauft, Piotr Radojewski, Petar-Marko Spanjol, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2009
Noninvasive prediction of tumor responses to gemcitabine using positron emission tomographyRachel E Laing, Martin A Walter, Dean O Campbell, et al.
Journal of Translational Medicine|January 17, 2013
Somatostatin-based radiotherapy with [90Y-DOTA]-TOC in neuroendocrine tumors: long-term outcome of a phase I dose escalation studyNicolas Marincek, Ann-Catherine Jörg, Philippe Brunner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 23, 2018
MEK Inhibition Induces Therapeutic Iodine Uptake in a Murine Model of Anaplastic Thyroid CancerOussama ElMokh, Vincent Taelman, Piotr Radojewski, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 28, 2010
Small-animal PET/CT for monitoring the development and response to chemotherapy of thymic lymphoma in Trp53-/- miceMartin A Walter, Isabel J Hildebrandt, Katrin Hacke, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 15, 2011
Metabolic imaging allows early prediction of response to vandetanibMartin A Walter, Matthias R Benz, Isabel J Hildebrandt, et al.
Cancer|November 6, 2009
Procalcitonin levels predict clinical course and progression-free survival in patients with medullary thyroid cancerMartin A Walter, Christian Meier, Tanja Radimerski, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 18, 2010
Correlation of 6-18F-fluoro-L-dopa PET uptake with proliferation and tumor grade in newly diagnosed and recurrent gliomasBarbara J Fueger, Johannes Czernin, Timothy Cloughesy, et al.
JAMA Oncology|February 15, 2019
Therapeutic Options for Neuroendocrine Tumors: A Systematic Review and Network Meta-analysisReto M Kaderli, Marko Spanjol, Attila Kollár, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 18, 2009
18F-FDOPA PET and PET/CT accurately localize pheochromocytomasFarzin Imani, Vatche G Agopian, Martin S Auerbach, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 11, 2017
Reply: Diabetes Mellitus and Its Effects on All-Cause Mortality After Radiopeptide Therapy for Neuroendocrine Tumors: Methodologic IssuesMaria Umlauft, Piotr Radojewski, Petar-Marko Spanjol, et al.
Pageof 8